Release Summary

Immunomic Therapeutics, CEO Bill Hearl, Ph.D., will participate in a panel discussion on vaccines and infectious disease at the 10th Annual European Life Science CEO Forum and Exhibition.

Immunomic Therapeutics, Inc. (ITI)